Docetaxel polymer derivative, method for producing same and use of same

Details for Australian Patent Application No. 2009250393 (hide)

Owner NanoCarrier Co., Ltd.

Inventors Saito, Hiroyuki; Kato, Yasuki; Harada, Mitsunori

Agent Griffith Hack

Pub. Number AU-A-2009250393

PCT Pub. Number WO2009/142326

Priority 2009-060129 12.03.09 JP; 2008-135933 23.05.08 JP

Filing date 20 May 2009

Wipo publication date 26 November 2009

International Classifications

C08G 69/40 (2006.01) Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

C08G 81/00 (2006.01) Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers

Event Publications

2 December 2010 PCT application entered the National Phase

  PCT publication WO2009/142326 Priority application(s): WO2009/142326

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009250405-Toner, developer, toner accommodating container, process cartridge and image forming method

2009250386-Vascular aging inhibitor and anti-aging formulation